References
- MenezesAMPerez-PadillaRJardimJChronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence studyLancet200536695001875188116310554
- ManninoDMBuistASGlobal burden of COPD: risk factors, prevalence, and future trendsLancet2007370958976577317765526
- BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD study): a population–based prevalence studyLancet2007370958974175017765523
- Lopez-CamposJLRuiz-RamosMSorianoJBMortality trends in chronic obstructive pulmonary disease in Europe, 1994−2010: a join point regression analysisLancet Respir Med201421546224461902
- RycroftCEHeyesALanzaLBeckerKEpidemiology of chronic obstructive pulmonary disease: a literature reviewInt J Chron Obstruct Pulmon Dis20127745749422927753
- MenezesAMPérez-PadillaRWehrmeisterFCFEV1 is a better predictor of mortality than FVC: the PLATINO cohort studyPLoS One2014910e10973225285441
- ToTStanojevicSMooresGGlobal asthma prevalence in adults: findings from the cross-sectional world health surveyBMC Public Health20121220422429515
- Global Burden of Disease Study 2013. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. GBD 2013 Mortality and Causes of Death CollaboratorsLancet2015385996311717125530442
- BurneyPJarvisDPerez-PadillaRThe global burden of chronic respiratory disease in adultsInt J Tuberc Lung Dis2015191102025519785
- ChapmanKRManninoDMSorianoJBEpidemiology and costs of chronic obstructive pulmonary diseaseEur Respir J200627118820716387952
- BramanSSThe global burden of asthmaChest2006130Suppl 14S12S16840363
- BahadoriKDoyle-WatersMMMarraCEconomic burden of asthma: a systematic reviewBMC Pulm Med200992419454036
- Montes de OcaMHalbertRJTalamoCPaid employment in subjects with and without chronic obstructive pulmonary disease in five Latin American cities: the PLATINO studyInt J Tuberc Lung Dis20111591259126421943855
- WackerMEJörresRASchulzHDirect and indirect costs of COPD and its comorbidities: results from the German COSYCONET studyRespir Med20161112394626725462
- PunekarYSShuklaAMüllerovaHCOPD management costs according to the frequency of COPD exacerbations in UK primary careInt J Chron Obstruct Pulmon Dis201491657324426781
- PatelJGNagarSDalalAAIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesInt J Chron Obstruct Pulmon Dis20149328930024672234
- FooJLandisSHMaskellJContinuing to confront COPD international patient survey: economic impact of COPD in 12 countriesPLoS One2016114e015261827092775
- Jahnz-RozykKTargowskiTFromSCosts of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007 – results of multicenter Polish studyPol Merkur Lekarski200926153208214 Polish19388534
- NielsenRJohannessenABenediktsdottirBPresent and future costs of COPD in Iceland and Norway: results from the BOLD studyEur Respir J200934485085719357148
- OrnekTTorMAltinRClinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseInt J Med Sci20129428529022701335
- PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis201271175776423152680
- MiravitllesMMurioCGuerreroTGisbertRCosts of chronic bronchitis and COPD: a 1-year follow-up studyChest2003123378479112628879
- IvanovaJIBergmanRBirnbaumHGColiceGLSilvermanRAMcLaurinKEffect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthmaJ Allergy Clin Immunol201212951229123522326484
- López VarelaMVMontes de OcaMReyAAlejandro CasasAStirbulovRDi BoscioVDevelopment of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: the PUMA studyRespirology20162171227123427319305
- Casas HerreraAMontes de OcaMLópez VarelaMVAguirreCSchiaviEJardimJRCOPD underdiagnosis and misdiagnosis in a high-risk primary care population in four Latin American countries. A key to enhance disease diagnosis: the PUMA studyPLoS One2016114e015226627073880
- SchiaviEStirbulovRHernández VecinoRMercurioSDi BoscioVCOPD screening in primary care in four Latin American countries: methodology of the PUMA studyArch Bronconeumol2014501146947424816036
- Montes de OcaMLopez VarelaMVJardimJStirvulovRSurmontFBronchodilator treatment for COPD in primary care of four Latin America countries: the multinational, cross-sectional, non-interventional PUMA studyPulm Pharmacol Ther2016381101627113029
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- Lopez VarelaMVMontes de OcaMHalbertRJSex-related differences in COPD in five Latin American cities: the PLATINO studyEur Respir J20103651034104120378599
- de Miguel DiezJCarrasco GarridoPGarcía CarballoMDeterminants and predictors of the cost of COPD in primary care: a Spanish perspectiveInt J Chron Obstruct Pulmon Dis20083470171219281084
- MüllerováHLuCLiHTabbererMPrevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary carePLoS One201491e8554024427316
- de OcaMMTálamoCHalbertRJFrequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) studyChest20091361717819349388
- Montes de OcaMLópez VarelaMVLaucho-ContrerasMEClassification of COPD patients according to ALAT and GOLD staging systems using PUMA study dataArch Bronconeumol2016 in press
- BedouchPSadatsafaviMMarraCAFitzGeraldJMLyndLDTrends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort studyPLoS One2012712e5094923227222
- ShenolikarRSongXAndersonJAChuBCCantrellCRCosts of asthma among US working adultsAm J Manag Care201117640941621756011
- SullivanPWGhushchyanVHSlejkoJFBelozeroffVGlobeDRLinSLThe burden of adult asthma in the United States: evidence from the Medical Expenditure Panel SurveyJ Allergy Clin Immunol2011127236336921281868
- Gerhardsson de VerdierMAnderssonMKernDMZhouSTunceliOAsthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma aloneValue Health201518675976626409602
- RheeCKYoonHKYooKHMedical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthmaCOPD201411216317024111662